Abiopharma

🔍 Van Oene Mark (Executive)

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Report Date: 2025-08-18

Detailed Transactions and Holdings:

• Sold 26,836 shares of Common Stock at $1.311 per share (Direct)
  Date: 2025-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,920,035.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
• F2: This sale price represents the weighted average sale price of the shares sold ranging from $1.30 to $1.32 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.